Sakar Healthcare Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Sakar Healthcare Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 17% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 89% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹181Over the last 3 years, every ₹100 of reported profit came with ₹181 of operating cash.
Higher than 83% of Healthcare companies in India.
Self-Funding Ratio
0.9×Over the last 3 years its own operating cash paid for 90% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 68% of Healthcare companies in India.
Cash Locked Ratio
₹27For every ₹100 of sales, ₹27 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹9 tied up three years earlier.
More money tied up than 56% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹15Sales grew 89% in 3 years; of every extra ₹100 of sales, ₹15 became extra profit.
Lower than 55% of Healthcare companies in India.
Asset Productivity Ratio
+89% / +43%In 3 years sales changed by +89% while total assets changed by +43%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
1.3×Debt due within a year is covered 1.3 times by its yearly operating cash.
Higher than 51% of Healthcare companies in India.
Cash Cushion Ratio
−3%Debt, after subtracting cash, equals 3% of its market value (net debt).
Lower than 58% of Healthcare companies in India.
Tangible Assets Ratio
98%Of every ₹100 the company owns, ₹98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 55% of Healthcare companies in India.
Tangible Net Worth Ratio
98%Of every ₹100 of net worth, ₹98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 57% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Sakar Healthcare Limited owes ₹0.33 for every ₹1 it owns. Net profit rose 74% in the year to Mar 2026, and grew 34% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
64.7Investors pay ₹64.7 for every ₹1 of Sakar Healthcare Limited's yearly profit, higher than 79% of Healthcare companies in India.
P/B ratio
6.02The share price is 6.02 times Sakar Healthcare Limited's book value per share, higher than 67% of Healthcare companies in India.
Market cap
₹1,953 CrThe total market value of all of Sakar Healthcare Limited's shares at today's price (share price × number of shares), smaller than 66% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹324 CrWhat Sakar Healthcare Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹147.82Net worth divided by the number of shares. The share price of ₹889.80 is 6.0 times this, which is the P/B above.
Return on equity (ROE)
9.4%Sakar Healthcare Limited earned 9.4% on its shareholders' money over the last year, lower than 70% of Healthcare companies in India.
Owes vs Owns
0.33×Sakar Healthcare Limited owes ₹0.33 for every ₹1 it owns (low), lower than 61% of Healthcare companies in India.
Dividend yield
NoneSakar Healthcare Limited does not currently pay a dividend.
Revenue growth
+42%Revenue rose 42% in the year to Mar 2026, and grew 24% a year on average over 3 years.
Profit growth
+74%Net profit rose 74% in the year to Mar 2026, and grew 34% a year on average over 3 years.
Profit margin
12.1%Sakar Healthcare Limited keeps ₹12 of every ₹100 of revenue as net profit.
Cash quality
1.6×Cash from Sakar Healthcare Limited's business was 1.6× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
6.1×Sakar Healthcare Limited's operating profit covered its interest costs 6.1 times in the year to Mar 2026.
Cash vs debt
Net debtSakar Healthcare Limited had ₹70 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Sakar Healthcare Limited's P/E ratio?
Investors pay ₹64.7 for every ₹1 of Sakar Healthcare Limited's yearly profit, higher than 79% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Sakar Healthcare Limited: ₹1,953 Cr ÷ ₹324 Cr (31 Mar 2026) = 6.0.
What is Sakar Healthcare Limited's return on equity?
Sakar Healthcare Limited earned 9.4% on its shareholders' money over the last year, lower than 70% of Healthcare companies in India.
How much does Sakar Healthcare Limited owe compared with what it owns?
Sakar Healthcare Limited owes ₹0.33 for every ₹1 it owns (low), lower than 61% of Healthcare companies in India.
Does Sakar Healthcare Limited pay a dividend?
No. Sakar Healthcare Limited does not currently pay a dividend.
Is Sakar Healthcare Limited's revenue growing?
Revenue rose 42% in the year to Mar 2026, and grew 24% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.